Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMitie Regulatory News (MTO)

Share Price Information for Mitie (MTO)

Share Price is delayed by 15 minutes
Get Live Data
165.00    -5.20 (-3.06%)
Bid:
164.90
Ask:
165.10
Spread: 0.20 (0.121%)
Market Cap: £2.07b
MTO Live PriceLast checked at - London Stock Exchange

Intraday Mitie Share Chart

Annual Financial Report

20 Jun 2025 11:00

RNS Number : 7748N
MITIE Group PLC
20 June 2025
Β 

Mitie Group plc

20 June 2025

LEI number: 213800MTCLTKEHWZMJ03

Β 

Mitie Group plc (the 'Company') - Annual Financial Report

Β 

Following the release on 5 June 2025 of the Company's full year results for the year ended 31 March 2025 (the 'Full Year Results Announcement'), the Company announces that it has published its Annual Report and Accounts for 2025 (the 'Annual Report').

Β 

The Company's 2025 Annual General Meeting (AGM) will be held at Level 12, The Shard, 32 London Bridge Street, London SE1 9SG on 22 July 2025 at 11:30am and will be viewable via webcast as described in Appendix 2 of the Notice of Annual General Meeting 2025 (the 'AGM Notice').

Β 

Copies of the Annual Report and the AGM Notice are available to view on the Company's website: www.mitie.com. Hard copies have been mailed to those shareholders who have elected to continue to receive paper communications. The Annual Report has been prepared using the single electronic reporting format specified in the TD ESEF Regulation.Β 

Β 

In accordance with Listing Rule 14.3.6 and DTR 6.3.5, a copy of the Annual Report, along with the AGM Notice and the form of proxy in relation to the AGM, are being submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

Β 

Β 

-Ends-

For further information, contact:

Kate Heseltine

Group IR & Corporate Finance Director

M: +44 (0)738 443 9112

E: kate.heseltine@mitie.comΒ 

Β 

Claire Lovegrove

Director of Corporate Affairs

M: +44 (0)790 027 6400

E: claire.lovegrove@mitie.com

Β 

Neil Bennett

H/Advisors Maitland

M: +44 (0)790 000 0777

E: mite@h-advisors.global

Β 

Β 

Β 

About Mitie: "Better places; Thriving Communities"

Β 

Founded in 1987, Mitie employs 72,000 colleagues and is the leading technology-led Facilities Transformation company in the UK. We are a trusted partner to a diverse range of blue chip customers across the public and private sectors, working with them to transform their built estates, and the lived experience for their colleagues and customers, as well as providing data-driven insights to inform better decision-making.

Β 

In each of our core services of engineering (hard services) and security and hygiene (soft services) we hold market leadership positions. We also deliver projects capabilities in the areas of power and grid connections, building fit outs & modernisation, decarbonisation, fire & security, and telecoms infrastructure. Our sector expertise includes central government, critical national infrastructure, defence, financial services, healthcare & life sciences, local government & education, retail & logistics and transport & aviation.

Β 

We hold industry-leading ESG credentials, including a place on the CDP Climate change A List, and we have received multiple industry awards recently including B2B Marketing Team of the Year, Best Low Carbon Solution and Net Zero Carbon Strategy of the year. Targeting Net Zero by the end of 2025, our ambitious emissions reduction plans have been validated by the Science Based Targets initiative (SBTi). We have been recognised as a UK Top Employer for the seventh consecutive year and Most Admired Company in the Support Services sector. Find out more at www.mitie.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
ACSPPUPUQUPAUBU
Date   Source Headline
4th Jun 20267:00 amRNSFull year results for the year ended 31 March 2026
1st Jun 20264:30 pmRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
26th May 20267:00 amRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
14th May 20264:30 pmRNSDirector/PDMR Shareholding
11th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20264:30 pmRNSTotal Voting Rights
27th Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:01 amRNSMitie enhances data centre projects capability
16th Apr 20267:00 amRNSFY26 Trading Update
15th Apr 20264:30 pmRNSDirector/PDMR Shareholding
13th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20264:45 pmRNSTotal Voting Rights
1st Apr 20264:30 pmRNSDirector/PDMR Shareholding
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20264:30 pmRNSDirector/PDMR Shareholding
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20265:45 pmRNSTotal Voting Rights
24th Feb 20264:45 pmRNSDirector/PDMR Shareholding
23rd Feb 20264:30 pmRNSDirector/PDMR Shareholding
16th Feb 20264:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.